Skip to main content

Biotricity Inc.

BTCY
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001630113

No open-market purchases or sales by Biotricity Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $5.99K in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Biotricity Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BTCY: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2215−16
Shares482.5K13.4K58.0K−411.1K (−87.6%)
Value$369.4K$12.0K$13.3K−$344.0K (−96.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (1)

Institutions that held Biotricity Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BTCY in Q3 2024
InstitutionSharesValue% of portfolio
Steward Partners Investment Advisory, LLC13$30.00%

Sold out (17)

Institutions that held Biotricity Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Biotricity Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BTCY in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.13,375$12.0K